Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44394 clinical trials with a EudraCT protocol, of which 7406 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,394)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,394 result(s) found. Displaying page 1,786 of 2,220.

EudraCT Number: 2017-002978-39

Sponsor Protocol Number: Ambulante_Geburtseinleitung

Start Date*: 2019-04-25

Sponsor Name:Medizinische Universität Graz

Full Title: Women's satisfaction with outpatient double-balloon catheter versus inpatient dinoprostone vaginal insert for induction of labour

Medical condition: Induction of labour

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10042613 - Surgical and medical procedures	10052856	Labour induction	PT

Population Age: Adults

Gender: Female

Trial protocol: AT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2017-002037-31

Sponsor Protocol Number: 2017/15

Start Date*: 2020-01-07

Sponsor Name:Centre Antoine-LACASSAGNE

Full Title: Study of the impact of DPD activity on the efficacy of capecitabine

Medical condition: Metastatic HER2-negative breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004864	10027475	Metastatic breast cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-001065-21

Sponsor Protocol Number: ET21-023

Start Date*: 2021-10-12

Sponsor Name:CENTRE LEON BERARD

Full Title: PAXIPEM - Multicenter phase II study of axitinib +/- pembrolizumab in first line treatment for patients with locally advanced or metastatic papillary renal cell carcinoma (PRCC)

Medical condition: Locally advanced or metastatic papillary cell carcinoma (PRCC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10050513	Metastatic renal cell carcinoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2016-003997-41

Sponsor Protocol Number: RC16_0019

Start Date*: 2017-10-09

Sponsor Name:CHU de Nantes

Full Title: Controlled and double blind comparison of a traditional dressing versus a biologic dressing composed of fetal fibroblasts and keratinocytes in association with a collagen matrix on skin donor sites

Medical condition: Split thickness skin graft

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004865	10041667	Split thickness skin graft	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2021-005721-25	Sponsor Protocol Number: Lifetime	Start Date*: 2023-07-05
Sponsor Name:Univeristy Hospital Tuebingen
Full Title: SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes - a randomized, placebo controlled, multi-center trial
Medical condition: The study will include adult male and female patients with an early stage of chronic kidney disease (CKD stage G1A2/G2A2) and prediabetes
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2019-000245-12

Sponsor Protocol Number: Repha_1436

Start Date*: 2020-01-20

Sponsor Name:Repha GmbH

Full Title: Controlled clinical trial to evaluate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhea-dominant irritable bowel syndrome (IBS-D) and patients with mixed-type ir...

Medical condition: A confirmed diagnosis of irritable bowel syndrome (IBS-D or IBS-M) by a specialist in gastroenterology and/or internal medicine and/or general medicine

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10017947 - Gastrointestinal disorders	10023002	Irritable bowel	LLT
	26.0	10017947 - Gastrointestinal disorders	10060845	Diarrhea predominant irritable bowel syndrome	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-001892-35

Sponsor Protocol Number: MK-7339-009

Start Date*: 2019-12-10

Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc

Full Title: An Open-label, Randomized, Phase 2/3 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction of Clinical Benefit With First-line Chemotherapy Plus Pembrolizumab ...

Medical condition: Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004864	10027475	Metastatic breast cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing) PL (Trial now transitioned) HU (Trial now transitioned) IE (Trial now transitioned) GB (GB - no longer in EU/EEA) FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2017-001139-38

Sponsor Protocol Number: 3475-689

Start Date*: 2018-02-02

Sponsor Name:Merck Sharp & Dohme LLC

Full Title: A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for StageIII-IVA Resectable Locoregionally Ad...

Medical condition: Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10060121	Squamous cell carcinoma of head and neck	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned) BE (Trial now transitioned) PT (Trial now transitioned) ES (Restarted) HU (Trial now transitioned) GB (GB - no longer in EU/EEA) PL (Trial now transitioned) FR (Trial now transitioned) AT (Trial now transitioned) IE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-001351-13

Sponsor Protocol Number: APHP201133

Start Date*: 2021-11-26

Sponsor Name:Assistance Publique des Hôpitaux de Paris(AP-HP)

Full Title: Interest of famotidine in reducing endothelial expression of P-selectin in children with sickle cell disease: pilot study, single-center, prospective, non-comparative

Medical condition: major sickle cell syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	10010331 - Congenital, familial and genetic disorders	10040644	Sickle cell disease	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-002442-20

Sponsor Protocol Number: 2019/2886

Start Date*: 2020-02-15

Sponsor Name:Gustave Roussy

Full Title: Study evaluating near infrared imaging coupled with indocyanine green for preoperative control of resection margins in ENT surgery.

Medical condition: visualization of the resection margins by near infrared fluorescence imaging (in vivo and ex vivo) for patients over 18 years of age with ENT epidermoid cancer treated by open surgery or by robot-a...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067821	Head and neck cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2015-005053-12

Sponsor Protocol Number: MK3475-204

Start Date*: 2016-06-01

Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Full Title: A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractory Classical Hodgkin Lymphoma

Medical condition: Relapsed or refractory classical Hodgkin lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004864	10020328	Hodgkin's lymphoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Trial now transitioned) DE (Trial now transitioned) PL (Trial now transitioned) FR (Trial now transitioned) CZ (Trial now transitioned) GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2022-001838-11	Sponsor Protocol Number: APHP211055	Start Date*: 2022-10-20
Sponsor Name:APHP DRCI
Full Title: Evaluation of low dose colchicine and ticagrelor in prevention of ischemic stroke in patients with stroke due to atherosclerosis. “Reducing inflammation in ischemic stroke with colchicine (riisc),...
Medical condition: Evaluation of low dose colchicine and ticagrelor in prevention of ischemic stroke in patients with stroke due to atherosclerosis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2021-000252-18

Sponsor Protocol Number: 35RC20_9803_RePERSO

Start Date*: 2021-04-27

Sponsor Name:Rennes University Hospital

Full Title: Evaluation of treatment PERSOnalization based on its therapeutic monitoring in patients with metastatic colorectal cancer treated with regorafenib

Medical condition: metastatic colorectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004864	10052362	Metastatic colorectal cancer	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2022-000174-25

Sponsor Protocol Number: 101090401IN

Start Date*: 2023-03-17

Sponsor Name:SANTEN INCORPORATED

Full Title: A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehi...

Medical condition: Fuchs Endothelial Corneal Dystrophy (FECD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004850	10014823	Endothelial corneal dystrophy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-002588-23

Sponsor Protocol Number: 2019/0407/HP

Start Date*: 2023-03-13

Sponsor Name:CHU de Rouen

Full Title: Neoadjuvant Chemotherapy for Obstructive Colon cancER first Treated by cOlostomy: A randomized phase III trial - COnCERTO (French 01-18)

Medical condition: Patients first treated by stoma and requiring chemotherapy for obstructive colon cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10009944	Colon cancer	PT
	20.0	10042613 - Surgical and medical procedures	10073254	Neoadjuvant therapy	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-005146-15

Sponsor Protocol Number: NIPIRESCUE_G-113

Start Date*: 2021-12-22

Sponsor Name:GERCOR

Full Title: Nivolumab and ipilimumab in patients with dMMR and/or MSI metastatic colorectal cancer resistant to anti-PD1 monotherapy: An open-label phase II GERCOR trial (NIPIRESCUE)

Medical condition: dMMR and/or MSI metastatic colorectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2018-001960-45	Sponsor Protocol Number: RC18_0206	Start Date*: 2019-04-15
Sponsor Name:CHU of Nantes
Full Title: An intensive program with quadruplet induction and consolidation plus tandem autologous stem cell transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients: a phase II study of the Int...
Medical condition: Young untreated patients with multiple myeloma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2022-002563-29	Sponsor Protocol Number: APHP211429	Start Date*: 2023-04-18
Sponsor Name:Assistance Publique – Hôpitaux de Paris (AP-HP)
Full Title: Colchicine versus Placebo in Acute Myocarditis Patients to Reduce Late Gadolinium Enhancement Mass on Cardiac Magnetic Resonance and the risk of Clinical Outcomes: The ARGO tria
Medical condition: NA
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-003318-10

Sponsor Protocol Number: D20180135

Start Date*: 2021-08-05

Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized...

Medical condition: Patients with a diagnosis of Eosinophilic Granulomatosis with Polyangiitis (EGPA) with newly-diagnosed disease or with a relapsing disease at the time of screening

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10021428 - Immune system disorders	10078117	Eosinophilic granulomatosis with polyangiitis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2017-004175-31	Sponsor Protocol Number: Prucalopride2017	Start Date*: 2018-04-09
Sponsor Name:TARGID, KU Leuven
Full Title: A placebo-controlled trial with prucalopride for the treatment of typical reflux symptoms in patients with gastro-esophageal reflux disease with incomplete proton pump inhibitor response
Medical condition: refractory gastro-esophageal reflux disease
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: BE (Trial now transitioned)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Wed Apr 22 06:16:26 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA